TFRC and lung cancer: Likewise, a study published in 2021 treated non‐small cell lung cancer with artemisinin derivatives ART and DHA that upregulated transferrin receptor (TFRC) and downregulated cystine/glutamate transporter (xCT) which are positive and negative mediators of ferroptosis, respectively [125].